Berger Mark Stanley 4

What Happened
Mark S. Berger, Chief Medical Officer of Genprex, had 7,168 shares withheld (disposed) on February 27, 2026 to satisfy tax withholding obligations related to the vesting of previously granted RSUs. The shares were valued at $2.00 each for a total of $14,336. The transaction is coded "F" on the Form 4, indicating tax withholding on equity awards rather than an open-market sale or purchase.

Key Details

• Transaction date: 2026-02-27
• Price per share: $2.00; Shares withheld/disposed: 7,168; Total value: $14,336
• Transaction code: F — shares withheld for tax withholding on RSU vesting
• Footnote: Withholding relates to RSUs granted under the Genprex, Inc. 2018 Equity Incentive Plan (as amended and restated effective June 30, 2025).
• Filing date/Period of report: 2026-02-27 (filed timely as reported)
• Shares owned after the transaction: not specified in the provided filing

Context
Share withholding to cover taxes on vested RSUs is a routine administrative disposition and does not represent a market-sale decision by the insider. It reduces the insider’s beneficial ownership by the withheld amount but is distinct from a voluntary sale or purchase that might signal sentiment.